In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...

Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month ...

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

NVO shares fall 19.9% year to date amid weak CagriSema data, CEO exit and rising pressure from rivals in obesity care.

Ozempic and rival products like Danish pharmaceutical giant Novo Nordisk's Wegovy have fueled a national obsession with medical weight loss. But pandemic-related demand spikes and supply constraints ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Find insight on Novo Nordisk, European drug exports, and more in the latest Market Talks covering Health Care.

National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...

In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...

By Rishika Sadam HYDERABAD (Reuters) -Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in ...